Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Growth is also driven by the rise of telehealth consultations and digital prescriptions, enabling easier patient access to GLP-1 therapies without visiting physical stores
A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is the first of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
from ICSTF of SINH, CAS for technical assistance
If you want to learn more about the side effects and safety of drugs like Ozempic and Wegovy, see our article here
"DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case-Control Study"
Clinical studies from 2025 show that post-surgical patients lose an average of 13.5% additional body weight when using GLP-1 agonists
US$ 23.65
US$ 21.59
US$ 28.12
US$ 27.68
US$ 23.98
US$ 20.44
US$ 23.06
